Asset Management Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Asset Management Group's GILD Position: Q1 2026 in Review
Asset Management Group reduced its Gilead Sciences (GILD) stake by 2.2% in Q1 2026, selling an estimated $7.42K and leaving 2,351 shares worth $328K. The position accounts for 0.05% of the portfolio, ranked #120.
Asset Management Group first reported a position in GILD in Q1 2020 and has held it in 19 quarters since. The position peaked at $697K in Q2 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Asset Management Group held 2,351 shares of Gilead Sciences worth $328K as of Q1 2026.
- Asset Management Group sold 53 Gilead Sciences shares in Q1 2026, an estimated $7.42K.
- Gilead Sciences made up 0.05% of Asset Management Group's portfolio in Q1 2026, its #120 holding.
- Asset Management Group first reported a position in Gilead Sciences in Q1 2020 and has held it in 19 quarters since.
- Asset Management Group's Gilead Sciences position peaked at $697K in Q2 2020.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Asset Management Group's 13F filing for Q1 2026, filed 15 May 2026.